Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
3,761–3,780 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
ANTXAN2 Therapeutics, Inc.$221.89M————$44.32M$13KAI pending
STIMNeuronetics, Inc.$221.73M—$149.16M+99.2%-$39M$19.2M$86.52MAI pending
HDSNHudson Technologies Inc$221.6M26.6×$246.61M+4.0%$16.67M$25.6M$4.76MAI pending
BRRProCap Financial, Inc.$221.37M—$85K—-$28.98M$15.34M$92.55MAI pending
KGEIKolibri Global Energy Inc.$221.32M11.5×$57.42M-2.1%$15.48M$2.8M$51.28MAI pending
HVIIHennessy Capital Investment Corp. VII$221.2M83.8×———$259.48K—AI pending
RICKRci Hospitality Holdings, Inc.$221.16M—$279.43M-5.5%$10.81M$26.4M$268.26MAI pending
CHCIComstock Holding Companies, Inc.$220.85M9.1×$62.86M+22.6%$17.05M$25.33M$4.86MAI pending
OVBCOhio Valley Banc Corp$220.76M15.5×$66.72M+7.6%$15.6M$78.08M$1.41MAI pending
DGACDISCIPLINED GROWTH ACQUISITION Corp$220.64M————$696.29K—AI pending
BGINBGIN BLOCKCHAIN Ltd$219.48M—$15.25M-92.1%-$176.95M$26.29M$219.8KAI pending
GAMGGlobal Asset Management Group, Inc.$218.76M—$95.31K+1,806.2%-$153.73K$64.18K—AI pending
CRBPCorbus Pharmaceuticals Holdings, Inc.$218.65M—$0-100.0%-$42.35M$23.37M$4.26MAI pending
CHRSCoherus Oncology, Inc.$218.62M—$42.17M+59.8%$168.02M$82.92M$2.41MAI pending
SZZLSizzle Acquisition Corp. II$218.46M41.6×———$340.15K—AI pending
ESOAEnergy Services of America CORP$218.41M19.4×$411M+16.8%—$14.68M$48.71MAI pending
ORGOOrganogenesis Holdings Inc.$218.1M—$564.17M+17.0%$37.03M$46.1M$36.57MAI pending
XYFX Financial$217.71M2.9×$1.09B+35.8%$209.43M$141.23M$65.09MAI pending
SVCOSilvaco Group, Inc.$217.55M—$63.06M+5.7%-$41.21M$13M$1.75MAI pending
PTACPatriot Acquisition Corp.$217.44M————$1.2M—AI pending